Johnson & Johnson and C.R. Bard have Removed Transvaginal Mesh Products from the Market
In June 2012, Johnson & Johnson’s Ethicon division announced that it would stop selling four types of mesh implants, GynecareTVTSecur™ System, GynecareProsima™ Pelvic Floor Repair System, GynecareProlift™ Pelvic Floor Repair System, and GynecareProlift+M™ Pelvic Floor Repair System, used to treat stress urinary incontinence. The company claimed that it was removing the products “in light of changing market dynamics, and is not related to safety or efficacy.” However, the timing is very coincidental in light of the FDA’s demand that the manufacturers test these products and monitor adverse event reports.
Similarly in July 2012, C.R. Bard stopped selling the AvaultaPlus Biosynthetic Support System. This was revealed after a $5.5 million verdict was obtained for a Plaintiff in California against C.R. Bard based on the AvaultaPlus Biosynthetic Support System.
Vaginal Mesh and Sling products remain a large portion of manufacturers’ profits and it has been reported that manufacturers have sold approximately $175 million worth of pelvic organ prolapse mesh and another $295 million for stress urinary incontinence in 2010.
For more information regarding transvaginal mesh lawsuits, please contact an experienced attorney at Pierce | Skrabanek. Our attorneys have handled medical device and pharmaceutical cases and are available for a free consultation. All cases are handled on a contingency basis meaning we don’t get paid until we win.